Scangos "working" on reuniting Biogen in Cambridge; Indian billionaire's 50-cent vax beats a jab from GSK;

@FierceBiotech: Cancer drug collaborations are hot. Story | Follow @FierceBiotech

@JohnCFierce: Interesting Xconomy piece on Somnus, but de-risked sleep meds relying on new delivery tech just looks weak to me. News | Follow @JohnCFierce

> George Scangos, the new CEO at Biogen Idec, has made no secret of his desire to reunite his headquarters team with its Cambridge R&D ops. In an interview with Xconomy, he says that "We're working on it. We'll see if it's practical." Story

> A 50-cent vaccine developed at the Serum Institute of India-head by billionaire Cyrus Poonawalla--worked better than a standard jab from GlaxoSmithKline at protecting people from meningitis. Story

> Cubist Pharmaceuticals says it has gathered positive top-line results from the recently completed Phase II studies of its CXA-201 and CB-183,315 antibiotic pipeline candidates. Report

> Glasgow-based Lamellar Biomedical says that its lead drug for cystic fibrosis has won orphan drug status from the European Commission. Release

Pharma News

@FiercePharma: Sanofi moves deeper into Genzyme operations. Item | Follow @FiercePharma

> Are drugmakers suffering from complexity? Article

> Analysts eye survivors of $250B patent cliff. Article

> Restaurateurs join call to lift MA gift ban. Story

> J&J to exit stents, cut 1,000 jobs. Report

> FDA highlights cancer risk with Takeda's Actos. News

Vaccines News

> Immatics starts late-stage cancer vaccine study. News 

> Type I diabetes nasal vaccine on the horizon. Item 

> GSK boosts China presence with flu vaccine buyout. Story

> BiondVax releases promising Ph2 universal flu vax results. Article

> Cheap meningitis vax beats out GSK's version. Story

> GSK, Arecor form vaccine stabilization pact. Article

Manufacturing News 

> Expert: FDA inadvertantly causing drug shortages. News

> APP expansion could help fight against drug shortages. Item 

> Dr. Reddy's tarnished by FDA warning, fire probe. Story 

> GSK deals to boost vax stability, fight flu in Asia. Report 

> Fidelity mutual fund rides big pharma profits. Item

And Finally... In the back-and-forth argument over the potential link between cell phones and brain cancer, a new study covered by Reuters Health says that most tumors found in the brain are not within the radius of the radiation mobile phones emit. Report